Page 74 - TD-3-3

Tumor Discovery Pyroptosis-related genes in breast cancer progression

approved and compliant with relevant research ethics 10. Chen C, Ye Q, Wang L, et al. Targeting pyroptosis in breast
standards. cancer: Biological functions and therapeutic potentials on It.
Cell Death Discov. 2023;9:75.
Consent for publication doi: 10.1038/s41420-023-01370-9

Not applicable. 11. Wang Y, Sun M, Liu J, et al. FIBCD1 overexpression predicts
poor prognosis in patients with hepatocellular carcinoma.
Availability of data Oncol Lett. 2020;19(1):795-804.
All data and materials supporting the findings of this doi: 10.3892/ol.2019.11183
work are available from the corresponding author upon 12. Vishnubalaji R, Alajez NM. Epigenetic regulation of triple
reasonable request. negative breast cancer (TNBC) by TGF-β signaling. Sci
Rep. 2021;11(1):15410.
References
doi: 10.1038/s41598-021-94514-9
1. Nolan E, Lindeman GJ, Visvader JE. Deciphering breast
cancer: From biology to the clinic. Cell. 2023;186(8): 13. Li S, Hao M, Li B, et al. CACNA1H downregulation induces
1708-1728. skeletal muscle atrophy involving endoplasmic reticulum
stress activation and autophagy flux blockade. Cell Death
doi: 10.1016/j.cell.2023.01.040 Dis. 2020;11(4):279.
2. Ye F, Dewanjee S, Li Y, et al. Advancements in clinical doi: 10.1038/s41419-020-2484-2
aspects of targeted therapy and immunotherapy in breast
cancer. Mol Cancer. 2023;22(1):105. 14. Sharma S, Wu SY, Jimenez H, et al. Ca2+ and CACNA1H
mediate targeted suppression of breast cancer brain
doi: 10.1186/s12943-023-01805-y metastasis by AM RF EMF. EBioMedicine. 2019;44:194-208.
3. Breast Cancer. Available from: https://www.who.int/news- doi: 10.1016/j.ebiom.2019.05.038
room/fact-sheets/detail/breast-cancer [Last accessed on
2024 Feb 21]. 15. Nanba K, Blinder AR, Rege J, et al. Somatic CACNA1H
mutation as a cause of aldosterone-producing adenoma.
4. GBD 2019 Diseases and Injuries Collaborators. Global burden Hypertens Dallas Tex 1979. 2020;75(3):645-649.
of 369 diseases and injuries in 204 countries and territories,
1990-2019: A systematic analysis for the Global Burden of doi: 10.1161/HYPERTENSIONAHA.119.14349
Disease Study 2019. Lancet. 2020;396(10258):1204-1222. 16. Bildik G, Liang X, Sutton MN, Bast RC, Lu Z. DIRAS3: An
doi: 10.1016/S0140-6736(20)30925-9 imprinted tumor suppressor gene that regulates RAS and
PI3K-driven cancer growth, motility, autophagy, and tumor
5. Zhou Z, He H, Wang K, et al. Granzyme A from cytotoxic dormancy. Mol Cancer Ther. 2022;21(1):25-37.
lymphocytes cleaves GSDMB to trigger pyroptosis in target
cells. Science. 2020;368(6494):eaaz7548. doi: 10.1158/1535-7163.MCT-21-0331
doi: 10.1126/science.aaz7548 17. Li H, Yang L, Fu H, et al. Association between Gαi2 and
ELMO1/Dock180 connects chemokine signalling with Rac
6. Xing Y, Zhang F, Ji P, et al. Efficient delivery of GSDMD-N activation and metastasis. Nat Commun. 2013;4:1706.
mRNA by engineered extracellular vesicles induces
pyroptosis for enhanced immunotherapy. Small. doi: 10.1038/ncomms2680
2023;19(20):2204031. 18. Yuan JQ, Zhang KJ, Wang SM, Guo L. YAP1/MMP7/CXCL16
axis affects efficacy of neoadjuvant chemotherapy via tumor
doi: 10.1002/smll.202204031
environment immunosuppression in triple-negative breast
7. Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. cancer. Gland Surg. 2021;10(9):2799-2814.
Cell. 2024;187(2):235-256.
doi: 10.21037/gs-21-612
doi: 10.1016/j.cell.2023.11.044
19. Sizemore ST, Sizemore GM, Booth CN, et al.
8. Guo X, Bian Y, Zhang Y, Yu H, Yu X. Research progress Hypomethylation of the MMP7 promoter and increased
of mechanism of non-coding RNA-regulated pyroptosis expression of MMP7 distinguishes the basal-like breast
in atherosclerosis. Pract J Card Cereb Pneumal Vasc Dis. cancer subtype from other triple-negative tumors. Breast
2021;29(12):136-140. Cancer Res Treat. 2014;146(1):25-40.
9. Tsuchiya K. Inflammasome-associated cell death: doi: 10.1007/s10549-014-2989-4
Pyroptosis, apoptosis, and physiological implications. 20. Zhang Z, Yang M, Chen R, et al. IBP regulates epithelial-
Microbiol Immunol. 2020;64(4):252-269.
to-mesenchymal transition and the motility of breast
doi: 10.1111/1348-0421.12771 cancer cells via Rac1, RhoA and Cdc42 signaling pathways.

Volume 3 Issue 3 (2024) 15 doi: 10.36922/td.3469